Form 4: Health In Tech: Insider Granted 5,000 Restricted Shares

Sentiment:

Insider Transaction Report


John McStravock, General Counsel of Health In Tech, Inc., received a grant of 5,000 restricted Class A Common Stock shares.

Summary

  • John McStravock, General Counsel for Health In Tech, Inc., was granted 5,000 shares of Class A Common Stock.
  • These shares are part of the Health In Tech Equity Incentive Plan.
  • The restricted shares will vest monthly over a 12-month period, starting April 6, 2026, contingent on continued employment.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine insider stock grant for compensation purposes and does not provide new financial information or strategic insights.

Positives

  • Grant of restricted stock indicates management's commitment and alignment with company performance.
  • The equity incentive plan suggests a strategy to retain key talent like the General Counsel.

Risks

  • Vesting is contingent on continued service, meaning departure before vesting would result in forfeiture of unvested shares.
  • The value of the granted shares is subject to market fluctuations of Health In Tech's Class A Common Stock.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future financial performance. It solely reports a transaction related to employee compensation.

Industry Context

StockSavvy.ai notes that grants of restricted stock are a common practice in the technology and healthcare sectors, particularly for key executives, to incentivize long-term performance and retention. This aligns with industry standards for executive compensation.

Comparison to Industry Standards

  • The granting of restricted stock to General Counsel is a standard practice across the technology and healthcare industries.
  • Vesting schedules of 12 months for a portion of executive grants are common, though longer periods (3-4 years) are also prevalent for more senior roles or larger grants.

Stakeholder Impact

  • Shareholders: The grant itself does not immediately impact share price but represents an increase in outstanding shares upon vesting, subject to dilution. It signals management's commitment.
  • Employees: Reinforces the company's use of equity incentives for talent retention.
  • Management: Aligns the General Counsel's interests with those of the company and its shareholders through equity ownership.

Next Steps

  • Continued service by John McStravock to meet vesting requirements.
  • Monthly vesting of restricted shares over the next 12 months.

Key Dates

DateDescription
04/06/2026Commencement date for the monthly vesting of restricted shares.
04/10/2026Transaction date for the grant of restricted stock.
04/13/2026Date of signature for the filing.

Keywords

SEC Form 4, Insider Trading, Restricted Stock, Equity Incentive Plan, Health In Tech, HIT, General Counsel, Stock Grant, Vesting Schedule

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.